Special Report

A 3-part discussion on a recent scientific statement on the role and utility of lipoprotein apheresis from the American Heart Association, hosted by document chair Laurence Sperling, MD, and vice-chair Eugenia Gianos, MD.

A multipart discussion, filmed immediately following the seladelpar decision, examining how recent advances have changed discussions in the managament of primary biliary cholangitis, with expert perspectives from Nancy Reau, MD, Palak Trivedi, MD, PhD, and Gideon Hirschfield, PhD, MB BChir.

In recognition of Hepatitis Awareness Month and Hepatitis Testing Day, this HCPLive Special Report spotlights a conversation between subject matter experts on updates and unmet needs in the management of hepatitis B virus in 2024.

Ophthalmologists Veeral Sheth, MD, and David Lally, MD provide an overview of geographic atrophy, an advanced stage of dry age-related macular degeneration, and describe the unfolding treatment landscape for the disease.

Expert advanced practice providers in the field of dermatology are sharing their experience and knowledge in treating patients with hidradenitis suppurativa. They are discussing the impact of this chronic disease on the quality of life of patients, as well as new insights in the pathophysiology of hidradenitis suppurativa guiding the development of novel treatments.

Dermatologists Drs Neal Bhatia and Dr Leon Kircik discuss topical treatments and how recent approval of a novel topical PDE4 inhibitor is likely to impact the treatment landscape of plaque psoriasis.

David P. Hudesman, shares insight on long-term extension data and clinical implications from ACG 2022 on the use of ustekinumab for the management of ulcerative colitis.

Insight from gastroenterology specialists on implications for treating patients with ulcerative colitis with newer novel therapies as recently presented at DDW 2021.